CORDIS
EU research results

CORDIS

English EN

Development of a platform and toolkit for understanding interactions between nanoparticles and the living world

Project information

Grant agreement ID: 33231

  • Start date

    1 January 2007

  • End date

    31 December 2009

Funded under:

FP6-NMP

  • Overall budget:

    € 4 616 544

  • EU contribution

    € 3 300 000

Coordinated by:

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland

Objective

We combine state-of-the-art techniques, methodologies, skills and instrumentation from several scientific arenas to create discipline-independent platforms to address key questions in nanotoxicology. Thus, we identify the routes via which nanoparticles enter and accumulate in living organisms, and connect this to representative cell-nanoparticle systems. Then using the most advanced methods of chemical, physical, biological and toxicological sciences we connect nanoparticle properties (in physiological conditions) to the mechanisms via which they interact with, and disrupt, cellular processes. We establish means and protocols via which every step of the program will be controlled, eliminating the factors that currently cause irreproducibilities. We emphasize novel unbiased assessments of intra- and inter-cellular processes after exposure to nanoparticles, enabling us to explore known, and unknown, processes.

Key companies, large and small from several end-user groups, that are currently facing the challenge of applying nanotechnology in their products are built into the program in a substantial manner, and other key stake-holders are also incorporated into the overall consortium via the Advisory Board. This will ensure maximum uptake of the knowledge generated by NanoInteract, and enable development of Standards for nanoparticle risk assessment.

Coordinator

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Address

Belfield Campus 4
Dublin

Ireland

Participants (17)

DSM INNOVATION CENTER B.V.

Netherlands

GLANTREO LIMITED

Ireland

INSTYTUT MEDYCYNY PRACY NOFER

Poland

INTEL PERFORMANCE LEARNING SOLUTIONS LIMITED

Ireland

L'OREAL SA

France

LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHEN

Germany

LUNDS UNIVERSITET

Sweden

MEDTRONIC BAKKEN RESEARCH CENTER B.V.

Netherlands

RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU

Netherlands

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

THE PROVOST, FELLOWS AND SCHOLARS OF THE COLLEGE OF THE HOLY AND UNDIVIDED TRINITY OF QUEEN ELIZABETH, NEAR DUBLIN

Ireland

UMICORE SA/NV

Belgium

UNIVERSITE PARIS SUD

France

UNIVERSITEIT GENT

Belgium

UNIVERSITY OF ULSTER

United Kingdom

WEIZMANN INSTITUTE OF SCIENCE

Israel

WILLIAM MARSH RICE UNIVERSITY

United States

Project information

Grant agreement ID: 33231

  • Start date

    1 January 2007

  • End date

    31 December 2009

Funded under:

FP6-NMP

  • Overall budget:

    € 4 616 544

  • EU contribution

    € 3 300 000

Coordinated by:

UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN

Ireland